Table 10.
One-, Five-, and Ten-Year Relative Survival Ratesa,b (RS) with 95% Confidence Intervals for Brain and Other Central Nervous System Tumors by Histopathology and Behavior, Overall and by NCI Age Group at Diagnosis, CBTRUS Statistical Report: US Cancer Statistics—NPCR and SEER, 2001-2019 (varying)
| Histopathology | Age Groups (years) | All (2004-2019) | Malignant (2001-2019)c | Non-Malignant (2004-2019)d | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | 1-Year RS (95% CI) | 5-Year RS (95% CI) | 10-Year RS (95% CI) | Nf | 1-Year RS (95% CI) | 5-Year RS (95% CI) | 10-Year RS (95% CI) | Ne | 1-Year RS (95% CI) | 5-Year RS (95% CI) | 10-Year RS (95% CI) | ||
| Diffuse astrocytoma | 0-14g | 2,080 | 92.2 (91.0-93.3) | 82.4 (80.7-84.1) | 80.0 (78.1-81.8) | 2,586 | 91.9 (90.8-92.9) | 81.5 (79.9-83.0) | 79.4 (77.6-81.0) | -- | -- | -- | -- |
| 15-39h | 6,663 | 95.7 (95.1-96.1) | 78.2 (77.1-79.3) | 61.5 (59.9-63.0) | 7,919 | 95.1 (94.6-95.6) | 77.1 (76.1-78.1) | 59.9 (58.5-61.2) | -- | -- | -- | -- | |
| 40+ | 11,841 | 63.3 (62.4-64.2) | 34.0 (33.1-35.0) | 25.5 (24.5-26.5) | 14,294 | 61.7 (60.8-62.5) | 32.9 (32.0-33.7) | 24.2 (23.3-25.1) | -- | -- | -- | -- | |
| All ages | 20,584 | 76.8 (76.2-77.4) | 53.5 (52.7-54.2) | 43.0 (42.2-43.9) | 24,799 | 75.6 (75.1-76.2) | 52.3 (51.7-53.0) | 41.8 (41.1-42.5) | 55 | 86.5 (73.4-93.5) | 78.0 (62.7-87.6) | 64.9 (46.1-78.5) | |
| Anaplastic astrocytoma | 0-14 | 660 | 67.5 (63.7-70.9) | 25.3 (21.8-28.9) | 19.4 (16.0-23.1) | 751 | 66.6 (63.1-69.9) | 24.9 (21.6-28.2) | 19.6 (16.5-22.9) | -- | -- | -- | -- |
| 15-39 | 4,138 | 92.3 (91.4-93.1) | 63.0 (61.3-64.6) | 46.8 (44.7-48.8) | 4,815 | 91.4 (90.5-92.1) | 61.5 (59.9-63.0) | 45.6 (43.8-47.4) | -- | -- | -- | -- | |
| 40+ | 10,277 | 57.5 (56.5-58.5) | 20.4 (19.5-21.2) | 14.5 (13.6-15.4) | 12,169 | 55.9 (54.9-56.8) | 19.8 (19.0-20.6) | 14.2 (13.4-15.0) | -- | -- | -- | -- | |
| All ages | 15,075 | 67.5 (66.7-68.2) | 32.2 (31.3-33.0) | 23.5 (22.7-24.4) | 17,735 | 65.9 (65.2-66.7) | 31.3 (30.5-32.1) | 22.9 (22.2-23.7) | -- | -- | -- | -- | |
| Glioblastoma | 0-14 | 1,119 | 57.6 (54.6-60.5) | 19.5 (17.0-22.0) | 16.2 (13.8-18.8) | 1,299 | 57.0 (54.2-59.7) | 20.4 (18.1-22.8) | 17.2 (15.0-19.6) | -- | -- | -- | -- |
| 15-39 | 6,567 | 76.9 (75.9-78.0) | 27.3 (26.1-28.5) | 19.0 (17.8-20.2) | 7,658 | 76.1 (75.1-77.0) | 27.0 (25.9-28.1) | 19.0 (18.0-20.1) | -- | -- | -- | -- | |
| 40+ | 119,220 | 40.9 (40.6-41.2) | 5.6 (5.5-5.8) | 3.4 (3.2-3.5) | 137,363 | 39.4 (39.1-39.7) | 5.3 (5.2-5.5) | 3.3 (3.1-3.4) | -- | -- | -- | -- | |
| All ages | 126,906 | 42.9 (42.6-43.2) | 6.9 (6.8-7.1) | 4.3 (4.2-4.5) | 146,320 | 41.5 (41.2-41.8) | 6.7 (6.5-6.8) | 4.3 (4.1-4.4) | -- | -- | -- | -- | |
| Oligodendroglioma | 0-14 | 269 | 97.4 (94.6-98.8) | 94.3 (90.6-96.5) | 92.3 (87.9-95.1) | 353 | 97.2 (94.8-98.5) | 94.3 (91.2-96.3) | 91.9 (88.2-94.5) | -- | -- | -- | -- |
| 15-39 | 3,949 | 98.6 (98.1-98.9) | 92.7 (91.7-93.5) | 79.0 (77.3-80.7) | 4,823 | 98.6 (98.2-98.9) | 92.4 (91.6-93.2) | 78.2 (76.7-79.6) | -- | -- | -- | -- | |
| 40+ | 5,526 | 92.8 (92.1-93.5) | 78.2 (76.8-79.4) | 64.5 (62.7-66.2) | 6,750 | 92.1 (91.4-92.8) | 77.1 (75.9-78.2) | 63.0 (61.5-64.5) | -- | -- | -- | -- | |
| All ages | 9,744 | 95.3 (94.8-95.7) | 84.6 (83.7-85.4) | 71.4 (70.1-72.6) | 11,926 | 94.9 (94.4-95.3) | 83.9 (83.1-84.7) | 70.2 (69.1-71.3) | -- | -- | -- | -- | |
| Anaplastic oligodendroglioma | 0-14 | -- | -- | -- | -- | 51 | 84.4 (71.1-91.9) | 61.5 (46.2-73.6) | 50.9 (35.3-64.6) | -- | -- | -- | -- |
| 15-39 | -- | -- | -- | -- | 1,575 | 95.6 (94.4-96.5) | 78.5 (76.1-80.6) | 64.1 (61.1-67.0) | -- | -- | -- | -- | |
| 40+ | 3,032 | 86.2 (84.9-87.4) | 61.0 (59.0-63.0) | 48.1 (45.6-50.5) | 3,713 | 84.4 (83.2-85.6) | 57.2 (55.4-59.0) | 44.7 (42.6-46.7) | -- | -- | -- | -- | |
| All ages | 4,342 | 89.1 (88.0-90.0) | 66.8 (65.2-68.4) | 53.0 (51.0-55.0) | 5,339 | 87.7 (86.8-88.6) | 63.6 (62.2-65.1) | 50.6 (48.9-52.3) | -- | -- | -- | -- | |
| Oligoastrocytic tumors | 0-14 | 147 | 91.2 (85.2-94.8) | 78.5 (70.8-84.4) | 76.1 (68.0-82.3) | 187 | 90.4 (85.1-93.9) | 76.2 (69.3-81.7) | 74.3 (67.3-80.1) | -- | -- | -- | -- |
| 15-39 | 2,400 | 97.5 (96.8-98.1) | 81.2 (79.5-82.7) | 61.0 (58.7-63.2) | 2,933 | 97.3 (96.6-97.8) | 79.9 (78.3-81.3) | 59.7 (57.7-61.7) | -- | -- | -- | -- | |
| 40+ | 2,896 | 82.7 (81.2-84.0) | 54.7 (52.8-56.6) | 43.7 (41.7-45.8) | 3,497 | 81.7 (80.4-83.0) | 53.2 (51.4-54.9) | 42.1 (40.2-43.9) | -- | -- | -- | -- | |
| All ages | 5,443 | 89.5 (88.6-90.3) | 67.1 (65.8-68.4) | 52.3 (50.8-53.8) | 6,617 | 88.9 (88.1-89.6) | 65.7 (64.5-66.9) | 50.9 (49.5-52.2) | -- | -- | -- | -- | |
| Pilocytic astrocytoma | 0-14 | 8,289 | 99.0 (98.7-99.2) | 97.3 (96.9-97.7) | 95.9 (95.3-96.4) | 9,383 | 98.8 (98.6-99.0) | 97.1 (96.7-97.4) | 95.5 (95.0-96.0) | 232 | 100.0 (**-**) | -- | -- |
| 15-39 | 3,977 | 98.5 (98.1-98.9) | 94.7 (93.9-95.4) | 93.0 (91.9-94.0) | 4,608 | 98.4 (98.0-98.8) | 94.6 (93.8-95.3) | 92.9 (91.9-93.7) | -- | -- | -- | -- | |
| 40+ | 1,351 | 91.9 (90.2-93.3) | 79.6 (76.9-82.1) | 77.2 (73.6-80.3) | 1,547 | 91.5 (89.9-92.9) | 79.0 (76.4-81.3) | 77.1 (73.9-79.9) | -- | -- | -- | -- | |
| All ages | 13,617 | 98.1 (97.9-98.4) | 94.8 (94.4-95.2) | 93.2 (92.6-93.7) | 15,538 | 98.0 (97.7-98.2) | 94.6 (94.1-94.9) | 92.9 (92.4-93.4) | 267 | 100.0 (**-**) | -- | -- | |
| Unique astrocytoma variants | 0-14 | 1,036 | 97.7 (96.5-98.4) | 94.8 (93.1-96.1) | 92.4 (90.1-94.2) | 383 | 95.7 (93.1-97.4) | 87.8 (83.8-90.9) | 82.6 (77.5-86.7) | 698 | 98.6 (97.3-99.3) | 98.0 (96.4-98.8) | 96.6 (94.3-98.0) |
| 15-39 | 968 | 96.8 (95.4-97.7) | 86.8 (84.2-89.0) | 82.0 (78.8-84.8) | 719 | 96.6 (95.0-97.8) | 82.5 (79.2-85.3) | 77.7 (73.8-81.1) | 342 | 97.0 (94.5-98.4) | 94.2 (90.7-96.4) | 91.0 (86.2-94.2) | |
| 40+ | 349 | 84.0 (79.5-87.6) | 59.3 (53.1-64.8) | 51.1 (43.9-57.8) | 300 | 81.6 (76.5-85.7) | 52.8 (46.4-58.9) | 48.0 (40.7-54.8) | 83 | 91.5 (82.1-96.1) | 82.6 (69.7-90.4) | 64.6 (46.4-77.9) | |
| All ages | 2,353 | 95.3 (94.3-96.1) | 86.4 (84.7-87.8) | 82.2 (80.2-84.0) | 1,402 | 93.2 (91.7-94.4) | 77.7 (75.2-79.9) | 72.8 (69.9-75.5) | 1,123 | 97.6 (96.5-98.4) | 95.8 (94.2-96.9) | 92.8 (90.5-94.6) | |
| Ependymal tumors | 0-14 | 2,467 | 95.6 (94.7-96.4) | 80.3 (78.5-82.0) | 72.0 (69.7-74.1) | 2,577 | 94.7 (93.7-95.5) | 76.8 (75.0-78.5) | 67.3 (65.1-69.4) | 281 | 99.7 (97.0-100.0) | 97.6 (94.3-99.0) | 97.6 (94.3-99.0) |
| 15-39 | 5,029 | 98.4 (97.9-98.7) | 94.8 (94.0-95.5) | 91.8 (90.7-92.7) | 3,244 | 97.2 (96.6-97.8) | 91.2 (90.1-92.2) | 87.2 (85.7-88.5) | 2,252 | 99.5 (99.1-99.8) | 99.1 (98.3-99.5) | 97.8 (96.5-98.7) | |
| 40+ | 9,571 | 94.9 (94.4-95.4) | 90.9 (90.0-91.7) | 87.7 (86.4-88.9) | 5,801 | 93.0 (92.3-93.7) | 86.6 (85.5-87.7) | 83.0 (81.4-84.4) | 4,602 | 96.7 (96.0-97.3) | 95.2 (94.0-96.2) | 92.9 (90.8-94.4) | |
| All ages | 17,067 | 96.0 (95.7-96.4) | 90.5 (89.9-91.0) | 86.6 (85.8-87.4) | 11,622 | 94.6 (94.1-95.0) | 85.7 (84.9-86.4) | 80.6 (79.7-81.6) | 7,135 | 97.7 (97.3-98.1) | 96.6 (95.8-97.2) | 94.7 (93.4-95.8) | |
| Glioma malignant, NOS | 0-14 | 6,223 | 81.3 (80.3-82.3) | 68.9 (67.7-70.1) | 67.9 (66.6-69.1) | 7,164 | 80.6 (79.7-81.5) | 67.7 (66.6-68.9) | 66.6 (65.5-67.8) | -- | -- | -- | -- |
| 15-39 | 3,805 | 91.3 (90.4-92.2) | 78.7 (77.2-80.1) | 72.1 (70.3-73.9) | 4,316 | 90.9 (90.0-91.7) | 77.7 (76.3-79.0) | 70.9 (69.2-72.5) | -- | -- | -- | -- | |
| 40+ | 8,027 | 53.0 (51.8-54.1) | 35.7 (34.5-36.9) | 29.8 (28.5-31.2) | 9,359 | 51.5 (50.4-52.5) | 34.1 (33.0-35.2) | 28.4 (27.2-29.6) | -- | -- | -- | -- | |
| All ages | 18,055 | 71.0 (70.3-71.7) | 56.5 (55.7-57.3) | 52.4 (51.5-53.2) | 20,839 | 69.8 (69.2-70.5) | 55.0 (54.3-55.8) | 50.9 (50.1-51.7) | -- | -- | -- | -- | |
| Other neuroepithelial tumors | 0-14 | 64 | 98.5 (89.0-99.8) | 91.4 (80.4-96.4) | 91.4 (80.4-96.4) | 55 | 98.2 (87.4-99.8) | 89.9 (77.3-95.7) | 89.9 (77.3-95.7) | -- | -- | -- | -- |
| 15-39 | 86 | 96.5 (89.2-98.9) | 88.2 (78.1-93.8) | 83.9 (70.9-91.4) | 66 | 95.5 (86.3-98.5) | 86.7 (74.7-93.3) | 78.8 (63.4-88.3) | -- | -- | -- | -- | |
| 40+ | 109 | 74.3 (64.6-81.8) | 52.5 (41.0-62.7) | 41.5 (28.8-53.7) | 56 | 69.0 (54.7-79.6) | 41.2 (26.8-55.1) | 31.6 (17.6-46.5) | 63 | 80.6 (67.5-88.8) | 59.4 (43.3-72.2) | 51.2 (33.2-66.6) | |
| All ages | 259 | 87.8 (83.0-91.4) | 74.6 (68.1-80.0) | 68.8 (61.1-75.3) | 177 | 88.0 (82.0-92.1) | 73.5 (65.6-79.8) | 67.2 (58.2-74.7) | 106 | 88.7 (80.4-93.6) | 76.0 (65.1-84.0) | 72.1 (59.7-81.3) | |
| Neuronal and mixed neuronal-glial tumors | 0-14 | 3,337 | 98.8 (98.3-99.1) | 96.1 (95.3-96.8) | 95.3 (94.4-96.1) | 293 | 92.4 (88.7-95.0) | 81.0 (75.8-85.2) | 79.5 (74.1-84.0) | 3,097 | 99.3 (98.9-99.6) | 97.4 (96.6-97.9) | 96.5 (95.6-97.3) |
| 15-39 | 5,108 | 98.4 (98.0-98.8) | 95.6 (94.9-96.2) | 92.7 (91.7-93.7) | 593 | 94.4 (92.1-96.0) | 79.3 (75.5-82.6) | 70.3 (65.6-74.4) | 4,592 | 98.9 (98.5-99.2) | 97.6 (97.0-98.1) | 95.6 (94.7-96.4) | |
| 40+ | 4,029 | 93.4 (92.5-94.2) | 85.2 (83.7-86.5) | 80.2 (78.1-82.1) | 1,637 | 90.5 (88.8-91.9) | 77.7 (75.1-80.1) | 69.2 (65.6-72.4) | 2,592 | 94.7 (93.7-95.6) | 89.4 (87.7-90.9) | 85.9 (83.4-88.0) | |
| All ages | 12,474 | 96.9 (96.6-97.2) | 92.4 (91.8-93.0) | 89.4 (88.6-90.2) | 2,523 | 91.6 (90.4-92.7) | 78.5 (76.5-80.3) | 70.8 (68.3-73.2) | 10,281 | 98.0 (97.7-98.3) | 95.5 (94.9-96.0) | 93.5 (92.7-94.2) | |
| Choroid plexus tumors | 0-14 | 948 | 95.9 (94.3-97.0) | 90.0 (87.7-91.8) | 88.0 (85.4-90.1) | 276 | 87.9 (83.4-91.3) | 65.7 (59.3-71.3) | 59.8 (52.9-66.1) | 710 | 98.3 (96.9-99.1) | 97.2 (95.5-98.3) | 96.6 (94.6-97.8) |
| 15-39 | 593 | 98.2 (96.7-99.0) | 95.9 (93.7-97.4) | 92.7 (89.3-95.0) | -- | -- | -- | -- | 554 | 98.2 (96.6-99.1) | 97.0 (95.0-98.2) | 95.5 (92.4-97.4) | |
| 40+ | 696 | 89.5 (86.8-91.7) | 84.9 (81.1-88.0) | 79.1 (73.4-83.6) | -- | -- | -- | -- | 647 | 90.5 (87.8-92.7) | 86.5 (82.6-89.6) | 81.5 (75.5-86.1) | |
| All ages | 2,237 | 94.5 (93.4-95.5) | 90.0 (88.4-91.3) | 86.6 (84.5-88.5) | 373 | 87.2 (83.2-90.3) | 67.3 (61.9-72.1) | 58.5 (52.3-64.1) | 1,911 | 95.7 (94.6-96.6) | 93.7 (92.2-94.9) | 91.4 (89.3-93.2) | |
| Tumors of the pineal region | 0-14 | 384 | 88.8 (85.1-91.6) | 67.5 (62.1-72.2) | 61.4 (55.5-66.8) | 377 | 85.6 (81.5-88.8) | 60.9 (55.4-65.9) | 53.8 (47.9-59.4) | 61 | 98.4 (88.5-99.8) | 98.4 (88.5-99.8) | 95.6 (81.6-99.0) |
| 15-39 | 712 | 95.5 (93.6-96.8) | 87.2 (84.1-89.7) | 81.9 (78.0-85.2) | 427 | 93.6 (90.8-95.6) | 75.7 (70.7-79.9) | 66.3 (60.3-71.5) | 339 | 97.1 (94.5-98.5) | 96.8 (93.8-98.3) | 94.9 (90.6-97.3) | |
| 40+ | 762 | 90.4 (87.9-92.4) | 80.0 (76.2-83.2) | 69.8 (64.4-74.6) | 352 | 86.6 (82.3-89.9) | 69.1 (63.0-74.3) | 56.0 (48.4-62.9) | 443 | 92.5 (89.3-94.8) | 87.3 (82.5-90.8) | 79.7 (72.4-85.3) | |
| All ages | 1,858 | 92.0 (90.6-93.2) | 80.1 (77.9-82.1) | 72.8 (69.9-75.5) | 1,156 | 88.9 (86.8-90.6) | 68.8 (65.7-71.6) | 59.2 (55.5-62.6) | 843 | 94.8 (92.9-96.2) | 92.0 (89.3-94.0) | 87.3 (83.3-90.5) | |
| Embryonal tumors | 0-14 | 6,023 | 82.0 (81.0-83.0) | 64.1 (62.8-65.4) | 59.0 (57.6-60.4) | 7,125 | 81.6 (80.7-82.5) | 63.2 (62.0-64.4) | 58.2 (57.0-59.5) | -- | -- | -- | -- |
| 15-39 | 2,133 | 91.4 (90.1-92.6) | 71.9 (69.8-73.9) | 61.7 (59.2-64.2) | 2,571 | 90.7 (89.5-91.8) | 71.1 (69.2-73.0) | 61.2 (59.0-63.3) | -- | -- | -- | -- | |
| 40+ | 773 | 70.0 (66.5-73.1) | 46.0 (42.1-49.7) | 37.5 (33.2-41.7) | 899 | 70.0 (66.8-72.9) | 46.6 (43.0-50.0) | 37.5 (33.7-41.3) | -- | -- | -- | -- | |
| All ages | 8,929 | 83.2 (82.4-84.0) | 64.4 (63.3-65.4) | 57.7 (56.5-58.9) | 10,595 | 82.8 (82.1-83.5) | 63.7 (62.7-64.7) | 57.2 (56.1-58.2) | -- | -- | -- | -- | |
| Nerve sheath tumors | 0-14 | 2,251 | 99.8 (99.4-99.9) | 98.9 (98.2-99.3) | 98.0 (97.2-98.6) | -- | -- | -- | -- | 2,216 | 100.0 (0.0-100.0) | 99.3 (98.7-99.6) | 98.5 (97.7-99.0) |
| 15-39 | 13,549 | 99.3 (99.1-99.4) | 98.5 (98.2-98.7) | 97.6 (97.1-98.0) | -- | -- | -- | -- | 13,406 | 99.5 (99.3-99.6) | 98.8 (98.5-99.0) | 98.0 (97.6-98.4) | |
| 40+ | 73,152 | 99.2 (99.1-99.3) | 99.2 (99.1-99.3) | 99.2 (99.1-99.3) | 496 | 86.2 (82.6-89.1) | 76.9 (72.2-80.9) | 72.9 (66.6-78.2) | 72,783 | 99.3 (99.1-99.4) | 99.3 (99.1-99.4) | 99.3 (99.1-99.4) | |
| All ages | 88,952 | 99.2 (99.1-99.3) | 99.2 (99.1-99.3) | 99.2 (99.1-99.3) | 720 | 85.0 (82.0-87.5) | 74.8 (71.0-78.1) | 70.0 (65.3-74.2) | 88,405 | 99.3 (99.2-99.4) | 99.3 (99.2-99.4) | 99.3 (99.2-99.4) | |
| Other tumors of cranial and spinal nerves | 0-14 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 15-39 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| 40+ | 56 | 97.8 (79.9-99.8) | 96.1 (75.2-99.4) | 91.5 (62.2-98.4) | -- | -- | -- | -- | 56 | 97.8 (79.9-99.8) | 96.1 (75.2-99.4) | 91.5 (62.2-98.4) | |
| All ages | 69 | 96.7 (85.4-99.3) | 93.8 (80.4-98.1) | 90.2 (69.6-97.1) | -- | -- | -- | -- | 69 | 96.7 (85.4-99.3) | 93.8 (80.4-98.1) | 90.2 (69.6-97.1) | |
| Meningiomas | 0-14 | 688 | 97.8 (96.3-98.7) | 95.4 (93.4-96.8) | 92.0 (89.1-94.2) | 60 | 90.0 (78.9-95.4) | 79.6 (66.8-87.9) | 74.8 (60.8-84.5) | 639 | 98.6 (97.3-99.3) | 96.5 (94.6-97.8) | 93.4 (90.4-95.4) |
| 15-39 | 24,271 | 98.8 (98.6-98.9) | 97.0 (96.8-97.3) | 94.9 (94.5-95.3) | 420 | 93.8 (91.0-95.8) | 84.4 (80.3-87.8) | 78.7 (73.7-82.8) | 23,943 | 98.9 (98.7-99.0) | 97.2 (97.0-97.5) | 95.2 (94.8-95.6) | |
| 40+ | 372,963 | 92.9 (92.8-93.0) | 87.4 (87.2-87.5) | 82.2 (82.0-82.5) | 4,678 | 83.1 (81.9-84.2) | 65.1 (63.4-66.8) | 58.0 (55.9-60.1) | 369,249 | 93.0 (92.9-93.1) | 87.6 (87.4-87.8) | 82.5 (82.2-82.8) | |
| All ages | 397,922 | 93.2 (93.1-93.3) | 88.0 (87.8-88.2) | 83.2 (82.9-83.4) | 5,158 | 84.1 (82.9-85.1) | 67.0 (65.4-68.5) | 60.1 (58.1-62.0) | 393,831 | 93.3 (93.2-93.4) | 88.3 (88.1-88.4) | 83.4 (83.2-83.7) | |
| Mesenchymal tumors | 0-14 | 1,285 | 97.8 (96.8-98.5) | 94.3 (92.7-95.5) | 92.4 (90.3-94.0) | 200 | 85.7 (80.0-89.9) | 69.1 (61.7-75.3) | 62.1 (54.1-69.1) | 1,118 | 99.4 (98.6-99.8) | 97.7 (96.5-98.6) | 96.5 (94.5-97.7) |
| 15-39 | 4,428 | 98.2 (97.7-98.6) | 95.8 (95.0-96.4) | 93.6 (92.5-94.5) | 545 | 91.9 (89.2-93.9) | 79.8 (75.9-83.1) | 71.7 (67.0-75.9) | 3,989 | 98.9 (98.5-99.2) | 97.5 (96.8-98.0) | 95.8 (94.8-96.7) | |
| 40+ | 10,582 | 94.2 (93.7-94.7) | 89.2 (88.3-90.0) | 84.1 (82.7-85.4) | 1,324 | 87.4 (85.3-89.2) | 69.1 (66.0-72.0) | 52.4 (48.3-56.2) | 9,453 | 95.0 (94.5-95.5) | 91.6 (90.7-92.4) | 87.8 (86.3-89.0) | |
| All ages | 16,295 | 95.6 (95.2-95.9) | 91.4 (90.8-92.0) | 87.4 (86.5-88.3) | 2,069 | 88.4 (86.9-89.8) | 72.1 (69.8-74.3) | 59.0 (56.1-61.8) | 14,560 | 96.4 (96.1-96.8) | 93.7 (93.1-94.2) | 90.7 (89.7-91.6) | |
| Primary melanocytic lesions | 0-14 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 15-39 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| 40+ | 191 | 70.2 (62.7-76.4) | 47.1 (38.2-55.4) | 31.3 (21.4-41.7) | 133 | 61.8 (52.6-69.8) | 34.2 (25.0-43.6) | 20.5 (11.6-31.1) | 76 | 86.1 (74.7-92.6) | 63.6 (47.6-75.9) | 44.9 (27.7-60.7) | |
| All ages | 263 | 69.3 (63.0-74.7) | 49.5 (42.2-56.4) | 35.9 (27.7-44.1) | 186 | 58.9 (51.3-65.8) | 35.2 (27.5-43.0) | 23.5 (15.7-32.3) | 102 | 87.6 (78.5-93.0) | 70.5 (57.8-80.0) | 55.0 (39.7-67.8) | |
| Lymphoma | 0-14 | 176 | 91.8 (86.5-95.1) | 86.5 (80.2-91.0) | 80.5 (72.1-86.6) | 197 | 91.7 (86.7-94.8) | 86.4 (80.4-90.6) | 81.7 (74.3-87.1) | -- | -- | -- | -- |
| 15-39 | 1,554 | 67.7 (65.3-70.0) | 59.6 (57.0-62.1) | 55.4 (52.5-58.2) | 1,923 | 63.4 (61.2-65.5) | 54.6 (52.3-56.9) | 50.7 (48.2-53.1) | -- | -- | -- | -- | |
| 40+ | 15,460 | 54.4 (53.6-55.3) | 36.6 (35.7-37.5) | 28.4 (27.4-29.5) | 17,909 | 53.7 (53.0-54.5) | 35.2 (34.4-36.1) | 26.6 (25.7-27.6) | -- | -- | -- | -- | |
| All ages | 17,190 | 56.1 (55.3-56.8) | 39.4 (38.6-40.2) | 31.8 (30.8-32.7) | 20,029 | 55.1 (54.3-55.8) | 37.8 (37.0-38.5) | 29.8 (29.0-30.7) | -- | -- | -- | -- | |
| Other hematopoietic neoplasms | 0-14 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 15-39 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| 40+ | 141 | 83.1 (75.3-88.6) | 67.0 (57.0-75.1) | 63.2 (51.6-72.7) | 174 | 82.5 (75.6-87.6) | 64.4 (55.7-71.9) | 59.9 (50.0-68.5) | -- | -- | -- | -- | |
| All ages | 157 | 84.8 (77.7-89.8) | 67.4 (58.1-75.1) | 64.0 (53.3-72.9) | 197 | 84.6 (78.3-89.1) | 66.4 (58.3-73.3) | 62.6 (53.5-70.4) | -- | -- | -- | -- | |
| Germ cell tumors | 0-14 | 1,414 | 93.5 (92.0-94.7) | 89.5 (87.6-91.0) | 86.7 (84.5-88.7) | 1,429 | 93.0 (91.5-94.2) | 87.8 (85.9-89.4) | 84.3 (82.0-86.3) | 186 | 92.6 (87.6-95.6) | 92.0 (86.9-95.2) | 92.0 (86.9-95.2) |
| 15-39 | 1,548 | 95.4 (94.2-96.4) | 89.6 (87.7-91.1) | 87.1 (85.0-89.0) | 1,653 | 94.5 (93.3-95.5) | 88.6 (86.8-90.1) | 85.9 (83.8-87.7) | 127 | 99.3 (93.4-99.9) | 93.3 (86.2-96.8) | 91.1 (83.0-95.4) | |
| 40+ | 196 | 92.5 (87.3-95.7) | 83.2 (75.5-88.6) | 78.6 (69.7-85.2) | 87 | 81.7 (71.3-88.6) | 63.5 (51.1-73.6) | 60.0 (45.7-71.6) | 124 | 98.5 (90.2-99.8) | 93.4 (82.7-97.6) | 86.8 (74.4-93.4) | |
| All ages | 3,158 | 94.3 (93.5-95.1) | 89.1 (87.9-90.3) | 86.5 (84.9-87.8) | 3,169 | 93.5 (92.6-94.3) | 87.5 (86.2-88.7) | 84.5 (82.9-85.9) | 437 | 96.2 (93.7-97.7) | 92.7 (89.2-95.1) | 90.2 (85.9-93.3) | |
| Tumors of the pituitary | 0-14 | 2,564 | 99.8 (99.5-99.9) | 99.4 (98.9-99.7) | 99.0 (98.2-99.4) | -- | -- | -- | -- | 2,562 | 99.8 (99.5-99.9) | 99.4 (98.9-99.7) | 99.0 (98.2-99.4) |
| 15-39 | 55,228 | 99.7 (99.7-99.8) | 99.4 (99.3-99.5) | 98.9 (98.7-99.0) | -- | -- | -- | -- | 55,155 | 99.7 (99.7-99.8) | 99.4 (99.3-99.5) | 98.9 (98.7-99.1) | |
| 40+ | 121,454 | 97.5 (97.4-97.7) | 95.9 (95.6-96.1) | 93.4 (93.0-93.8) | 371 | 88.4 (84.3-91.5) | 79.4 (73.6-84.1) | 70.0 (62.2-76.5) | 121,153 | 97.6 (97.5-97.7) | 95.9 (95.7-96.1) | 93.5 (93.1-93.9) | |
| All ages | 179,246 | 98.3 (98.2-98.3) | 97.0 (96.9-97.2) | 95.3 (95.0-95.6) | 476 | 90.6 (87.3-93.1) | 81.9 (77.2-85.7) | 74.7 (68.4-79.9) | 178,870 | 98.3 (98.2-98.4) | 97.1 (96.9-97.2) | 95.3 (95.1-95.6) | |
| Craniopharyngioma | 0-14 | 1,860 | 98.6 (98.0-99.1) | 95.8 (94.6-96.7) | 91.8 (90.1-93.3) | -- | -- | -- | -- | 1,851 | 98.7 (98.0-99.1) | 95.8 (94.7-96.7) | 91.9 (90.1-93.3) |
| 15-39 | 1,920 | 96.3 (95.3-97.0) | 91.5 (90.0-92.8) | 87.6 (85.6-89.3) | -- | -- | -- | -- | 1,918 | 96.2 (95.3-97.0) | 91.6 (90.1-92.9) | 87.7 (85.7-89.4) | |
| 40+ | 4,386 | 88.9 (87.9-89.9) | 78.5 (76.9-80.0) | 69.9 (67.7-71.9) | -- | -- | -- | -- | 4,377 | 89.0 (87.9-89.9) | 78.5 (77.0-80.0) | 69.9 (67.7-72.0) | |
| All ages | 8,166 | 92.9 (92.3-93.5) | 85.7 (84.7-86.5) | 79.5 (78.2-80.7) | -- | -- | -- | -- | 8,146 | 92.9 (92.3-93.5) | 85.7 (84.8-86.6) | 79.5 (78.2-80.8) | |
| Hemangioma | 0-14 | 598 | 99.4 (98.2-99.8) | 98.0 (96.4-98.9) | 98.0 (96.4-98.9) | -- | -- | -- | -- | 598 | 99.4 (98.2-99.8) | 98.0 (96.4-98.9) | 98.0 (96.4-98.9) |
| 15-39 | 2,725 | 99.6 (99.2-99.8) | 98.7 (97.9-99.1) | 97.1 (95.8-98.0) | -- | -- | -- | -- | 2,719 | 99.6 (99.3-99.8) | 98.7 (98.0-99.2) | 97.1 (95.8-98.0) | |
| 40+ | 5,577 | 96.1 (95.4-96.6) | 91.8 (90.6-92.9) | 89.4 (87.3-91.1) | -- | -- | -- | -- | 5,570 | 96.1 (95.4-96.7) | 91.9 (90.7-93.0) | 89.4 (87.4-91.2) | |
| All ages | 8,900 | 97.4 (97.0-97.8) | 94.4 (93.6-95.1) | 92.5 (91.3-93.6) | -- | -- | -- | -- | 8,887 | 97.4 (97.0-97.8) | 94.5 (93.7-95.2) | 92.6 (91.3-93.7) | |
| Neoplasm, unspecified | 0-14 | 1,460 | 88.5 (86.7-90.0) | 85.5 (83.5-87.2) | 84.0 (81.9-86.0) | 396 | 66.3 (61.4-70.8) | 58.0 (52.8-62.8) | 54.8 (49.4-59.9) | 1,108 | 95.3 (93.9-96.5) | 94.2 (92.6-95.5) | 93.4 (91.5-94.9) |
| 15-39 | 4,268 | 93.5 (92.7-94.2) | 90.2 (89.2-91.1) | 87.9 (86.7-89.0) | 869 | 79.3 (76.4-81.9) | 68.6 (65.2-71.7) | 63.2 (59.4-66.7) | 3,560 | 96.1 (95.4-96.7) | 94.1 (93.2-94.9) | 92.3 (91.1-93.3) | |
| 40+ | 21,433 | 54.4 (53.7-55.1) | 45.3 (44.5-46.1) | 40.2 (39.2-41.1) | 9,806 | 27.3 (26.4-28.3) | 17.7 (16.9-18.6) | 15.2 (14.3-16.2) | 13,267 | 71.4 (70.6-72.2) | 62.3 (61.3-63.3) | 55.7 (54.4-57.0) | |
| All ages | 27,161 | 62.6 (62.0-63.2) | 54.9 (54.2-55.6) | 50.6 (49.8-51.4) | 11,071 | 33.0 (32.1-34.0) | 23.5 (22.6-24.3) | 20.7 (19.7-21.6) | 17,935 | 77.9 (77.3-78.6) | 70.9 (70.1-71.7) | 65.9 (64.9-66.9) | |
| All other | 0-14 | 416 | 89.9 (86.5-92.5) | 85.0 (81.0-88.2) | 85.0 (81.0-88.2) | 124 | 60.5 (51.1-68.5) | 39.7 (30.6-48.8) | 38.2 (29.0-47.4) | 310 | 99.5 (97.0-99.9) | 99.5 (97.0-99.9) | 99.5 (97.0-99.9) |
| 15-39 | 368 | 98.1 (96.0-99.1) | 94.5 (91.2-96.6) | 92.9 (88.7-95.7) | -- | -- | -- | -- | 335 | 99.2 (97.1-99.8) | 97.9 (94.9-99.1) | 96.2 (91.7-98.3) | |
| 40+ | 572 | 87.6 (84.2-90.3) | 83.8 (78.7-87.7) | 74.4 (67.0-80.4) | -- | -- | -- | -- | 548 | 88.9 (85.4-91.6) | 85.5 (80.3-89.4) | 76.1 (68.3-82.2) | |
| All ages | 1,356 | 91.2 (89.4-92.7) | 87.1 (84.7-89.2) | 83.3 (80.0-86.1) | 194 | 65.9 (58.6-72.2) | 43.8 (36.2-51.2) | 40.8 (32.9-48.6) | 1,193 | 94.6 (92.9-95.9) | 92.8 (90.3-94.6) | 88.6 (85.1-91.4) | |
| TOTAL i | 0-14 | 46,102 | 91.6 (91.4-91.9) | 83.2 (82.8-83.6) | 80.7 (80.2-81.1) | 35,281 | 87.4 (87.1-87.8) | 75.0 (74.6-75.5) | 71.8 (71.3-72.3) | 16,035 | 98.9 (98.8-99.1) | 97.6 (97.3-97.8) | 96.4 (96.0-96.7) |
| 15-39 | 157,627 | 97.0 (96.9-97.1) | 91.1 (90.9-91.2) | 87.1 (86.9-87.3) | 52,117 | 90.7 (90.5-91.0) | 71.9 (71.5-72.3) | 61.5 (61.0-62.0) | 113,601 | 99.3 (99.2-99.3) | 98.4 (98.3-98.4) | 97.2 (97.0-97.3) | |
| 40+ | 805,163 | 83.2 (83.1-83.3) | 72.8 (72.7-72.9) | 68.9 (68.7-69.0) | 232,885 | 49.4 (49.2-49.6) | 21.1 (20.9-21.3) | 16.8 (16.6-17.0) | 605,615 | 94.2 (94.2-94.3) | 90.4 (90.3-90.5) | 86.8 (86.6-87.0) | |
| All ages | 1,008,892 | 85.8 (85.7-85.9) | 76.3 (76.1-76.4) | 72.4 (72.3-72.6) | 320,283 | 60.4 (60.3-60.6) | 35.7 (35.5-35.9) | 30.6 (30.4-30.8) | 735,251 | 95.1 (95.1-95.2) | 91.9 (91.7-92.0) | 88.8 (88.6-88.9) | |
aThe cohort analysis of survival rates was utilized for calculating the survival estimates presented in this table. Long-term cohort-based survival estimates reflect the survival experience of individuals diagnosed over the time periods, and they may not necessarily reflect the long-term survival outlook of newly diagnosed cases.
bRates are an estimate of the percentage of cases alive at one, two, five, and ten years, respectively. Rates were not presented for categories with 50 or fewer cases and were suppressed for rates where fewer than 16 cases were surviving within a category.
cAssigned behavior code of /3 (see Tables 2).
dAssigned behavior code of /0 or /1 (see Table 2).
eTotal number of cases that occurred within the included NPCR and SEER registries between 2004 and 2019.
fTotal number of cases that occurred within the included NPCR and SEER registries between 2001 and 2019.
gChildren as defined by the National Cancer Institute, see: http://www.cancer.gov/researchandfunding/snapshots/pediatric.
hAdolescents and Young Adults (AYA), as defined by the National Cancer Institute, see: http://www.cancer.gov/cancertopics/aya.
i Total includes histopathologies not listed in this table.
- Rates were not presented for categories with 50 or fewer cases and were suppressed for rates where fewer than 16 cases were surviving within a category.
** Confidence interval could not be calculated.
Abbreviations: CBTRUS, Central Brain Tumor Registry of the United States; NPCR, National Program of Cancer Registries; CI, confidence interval; NOS, not otherwise specified; RS, Relative survival.